Key result
Big endothelin-1 demonstrated significant prognostic value for cardiovascular mortality in hospitalized heart failure patients, improving risk prediction models beyond NT-proBNP alone.
Why the study?
Does big ET-1 measurement improve prognostication for cardiovascular mortality in hospitalized HF patients?
Does big ET-1 measurement improve prognostication for cardiovascular mortality in hospitalized HF patients?
Answers are grounded in this paper and cite their sources.
Big ET-1 provides complementary prognostic information to NT-proBNP for predicting cardiovascular mortality across the entire spectrum of heart failure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Dong‐Hyuk Cho (2025) conducted an editorial in Heart failure (n=4,368). Big endothelin-1 (ET-1) was evaluated on Cardiovascular mortality. Big endothelin-1 demonstrated significant prognostic value for cardiovascular mortality in hospitalized heart failure patients, improving risk prediction models beyond NT-proBNP alone.
Synapse has enriched 10 related papers. Consider them for comparative context: